Skip to main content

An Overview of Our Pipeline

Product Candidates
Pre-Clinical
Phase 1
Phase 2/3
Program Area: Systemic Rejuvenation and Longevity
MitoXcel™ Geropeptides
PTC-2105 (Mechanism 1 and 2)
LEAD CLINICAL CANDIDATE
Sarcopenia and Sarcopenic Obesity
PTC-2107 (Mechanism 1 and 2)
Neurodegenerative Disorders, e.g. ALZ, PDCognitive Decline of Aging
PTC-2113 (Mechanism 1)
Obesity and Glucose Metabolic Disorders
PTC-2118 (Mechanism 1 and 2)
Mitochondrial Rare Diseases
PTC-2105 for Sarcopenia/Sarcopenic Obesity